Growth Metrics

Adaptive Biotechnologies (ADPT) Long-Term Investments (2019 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Long-Term Investments for 6 consecutive years, with $13.2 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments fell 60.68% to $13.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.2 million through Dec 2025, down 60.68% year-over-year, with the annual reading at $13.2 million for FY2025, 60.68% down from the prior year.
  • Long-Term Investments hit $13.2 million in Q4 2025 for Adaptive Biotechnologies, up from $4.0 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $217.4 million in Q3 2021 to a low of $4.0 million in Q3 2025.
  • Historically, Long-Term Investments has averaged $70.6 million across 4 years, with a median of $33.7 million in 2024.
  • Biggest five-year swings in Long-Term Investments: soared 1220.17% in 2021 and later crashed 90.94% in 2022.
  • Year by year, Long-Term Investments stood at $217.1 million in 2021, then tumbled by 90.93% to $19.7 million in 2022, then skyrocketed by 70.88% to $33.7 million in 2024, then plummeted by 60.68% to $13.2 million in 2025.
  • Business Quant data shows Long-Term Investments for ADPT at $13.2 million in Q4 2025, $4.0 million in Q3 2025, and $24.1 million in Q2 2025.